000 01465 a2200409 4500
005 20250517215601.0
264 0 _c20190913
008 201909s 0 0 eng d
022 _a1477-2566
024 7 _a10.1016/j.jcyt.2018.03.039
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArcidiacono, Judith A
245 0 0 _aFDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products.
_h[electronic resource]
260 _bCytotherapy
_c06 2018
300 _a779-784 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiological Products
_xstandards
650 0 4 _aCooperative Behavior
650 0 4 _aDrug Approval
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aIntersectoral Collaboration
650 0 4 _aInventions
_xstandards
650 0 4 _aReference Standards
650 0 4 _aRegenerative Medicine
_xmethods
650 0 4 _aTherapies, Investigational
_xmethods
650 0 4 _aTranslational Research, Biomedical
_xmethods
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aBauer, Steven R
700 1 _aKaplan, David S
700 1 _aAllocca, Clare M
700 1 _aSarkar, Sumona
700 1 _aLin-Gibson, Sheng
773 0 _tCytotherapy
_gvol. 20
_gno. 6
_gp. 779-784
856 4 0 _uhttps://doi.org/10.1016/j.jcyt.2018.03.039
_zAvailable from publisher's website
999 _c28413982
_d28413982